-
US$33.00
US$54.00Kids-e-Crown Primary Second Molar Refills Pediatric Crowns
US$33.00US$54.00 -
US$39.00
US$88.00Kids-e-Dental E Splint Esthetic Fiber Reinforced Periodontal Splint
US$39.00US$88.00 -
Price range: US$599.00 through US$1,049.00
Kids-e-Crown Anterior Master Kit Universal Canines & Incisors Pediatric Crowns
Price range: US$599.00 through US$1,049.00 -
Price range: US$333.00 through US$799.00
Kids-e-Crown Primary First Molar Kit Pediatric Crowns
Price range: US$333.00 through US$799.00 -
e – MTA Carrier Dental Premium Quality ( EMTA )
- Made of Stainless Steel
- High Strength
- Autoclavable
- Curved design for easy access and better placement
US$35.00US$50.00e – MTA Carrier Dental Premium Quality ( EMTA )
US$35.00US$50.00 -
-
US$431.00
US$485.00Kids-e-Crown Primary First Molar Kits
US$431.00US$485.00 -
US$862.00
US$940.00Kids-e-Crown Anterior Master Kit -Universal Canines & Incisors
US$862.00US$940.00 -
-
-
-
US$32.00
US$37.00Kids-e-Dental Bands with tube attached Refills
US$32.00US$37.00 -
US$30.00
US$35.00Kids-e-Dental Curved Loops (Pk of 10)
US$30.00US$35.00 -
US$666.00
US$770.00Kids-e-Dental Space Maintainer All in one starter kit
US$666.00US$770.00 -
-
US$28.00
US$35.00Kids-e-Dental Straight Loops (Pk of 10)
US$28.00US$35.00 -
-
US$28.00
US$35.00Kids-e-Dental Distal Shoe Loops Pack of 5
US$28.00US$35.00 -
-
-
US$431.00
US$485.00Kids-e-Crown Primary Second Molar Kits
US$431.00US$485.00 -
US$35.00
US$39.00Indoco Warren Lignox Lignocaine 2% (Pack Of 24)
US$35.00US$39.00 -
US$799.00
US$970.00Kids-e-Crown Primary Second Molar Master Kit Pediatric Crowns
US$799.00US$970.00 -
e-MTA Dental Mineral Trioxide Aggregate
- Bio-Active
- Washout Resistant
- Quick Setting
- Smart Packaging
- Gel Based Technology
US$55.00US$90.00e-MTA Dental Mineral Trioxide Aggregate
US$55.00US$90.00
Indoco Remedies
Indoco Remedies Ltd. is a fully integrated, research-oriented pharmaceutical company that specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). With a remarkable presence of seven decades in the Indian Pharma market and a strong foothold in 55 countries globally, Indoco is dedicated to providing high-quality healthcare solutions. Founded in 1945 as the Indo-Continental Trading Company, the company initially focused on importing pharmaceutical formulations from Europe and distributing them in Western India. However, after India gained independence in 1947, the Indian government encouraged indigenous manufacturing, and Indoco Remedies Limited was established on August 23, 1947, with the aim of manufacturing and selling pharmaceutical formulations. Today, Indoco Remedies Ltd. stands as a USD 198 million company with a workforce of over 6,000 personnel, including more than 300 skilled scientists. The company operates nine manufacturing facilities, six for finished dosages and three for APIs, supported by a state-of-the-art R&D center in Rabale, Navi Mumbai, and a Clinical Research Organization in Hyderabad. These facilities adhere to the highest regulatory standards, complying with WHO-cGMP guidelines and obtaining approvals from esteemed regulatory authorities such as USFDA, UK-MHRA, TGA-Australia, SAHPRA-South Africa, NDA-Uganda, TFDA-Tanzania, MOH-Ukraine, PPB-Kenya, DPML-Ivory Coast, and many others. Indoco’s strong presence in international markets enables them to offer comprehensive solutions, including product development, manufacturing, and supply of Finished Dosages, APIs, and Intermediates to generic companies worldwide. With a wide range of products supported by ANDAs / eCTD Dossiers and Drug Master Files (DMFs), Indoco’s expertise in research & development, backward integration in select API products, their own CRO set-up, excellence in Finished Dosage manufacturing, and a robust customer base contribute to the consistent growth in both domestic and international business. Indoco Remedies Ltd. has received accolades for its contributions to the pharmaceutical industry, including the ‘IDMA Margi Patel Choksi Memorial Best Patent Awards 2019-2021’, showcasing its commitment to innovation and intellectual property rights. As a research-oriented pharmaceutical company, Indoco Remedies Ltd. remains dedicated to advancing healthcare through continuous improvement and delivering reliable healthcare solutions to patients worldwide.
























